Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Neurologica Belgica
Published in: Acta Neurologica Belgica 6/2023

20-03-2023 | Magnetic Resonance Imaging | Letter to the Editor

Anti-NMDA-receptor encephalitis, a challenging case leading to the discovery of a rapidly growing tumor

Authors: Julie Wénin, Maroussia Bronchain, Amina Sellimi, Vincent van Pesch

Published in: Acta Neurologica Belgica | Issue 6/2023

Login to get access

Excerpt

Anti-N-Methyl-D-Aspartate Receptor (anti-NMDAR) encephalitis is the most frequent autoimmune encephalitis mediated by antibodies against cell surface neuronal receptors. Its prognosis is favorable if treated timely and adequately. It may be in relation with underlying neoplasia, most frequently teratomas. Because the tumor can appear several months after the onset, oncological follow-up is crucial. We report here the case of an anti-NMDAR encephalitis with an unusual oncological course. A short-term clinical worsening, lead to the discovery of a rapidly growing tumor, that was not present at disease onset. …
Literature
1.
2.
Dalmau J, Tüzün E, Wu H et al (2007) Paraneoplastic anti- N -methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61(1):25–36CrossRefPubMedPubMedCentral
3.
Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neuroly 12(2):157–165CrossRef
4.
Omata T, Kodama K, Watanabe Y et al (2017) Ovarian teratoma development after anti-NMDA receptor encephalitis treatment. Brain Dev 39(5):448–451CrossRefPubMed
5.
Metadata
Title
Anti-NMDA-receptor encephalitis, a challenging case leading to the discovery of a rapidly growing tumor
Authors
Julie Wénin
Maroussia Bronchain
Amina Sellimi
Vincent van Pesch
Publication date
20-03-2023
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 6/2023
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-023-02241-x

Other articles of this Issue 6/2023

Acta Neurologica Belgica 6/2023 Go to the issue

Letter to the Editor

A case of pediatric Guillain–Barré syndrome following hand–foot–and–mouth disease and the need for Brighton criteria revision in children

Original article

Decreased SIRT1 mRNA expression in peripheral blood mononuclear cells from patients with neuromyelitis optica spectrum disorders

Original article

A nested case–control study investigating short-term prognosis, clinical and imaging features in acute ischemic stroke patients with systemic lupus erythematosus

Letter to the Editor

Non-dominant temporal lobe surgery: a case report of prosopagnosia following cavernous malformation resection

Original article

Extensive widening of Virchow-Robin spaces in the frontal lobe: two case reports and systematic review of the literature

Original article

The relation between the symbol digit modalities test, fatigue, depression, and anxiety symptoms in a Belgian MS cohort